(FY)Jan 31, 2020 | (FY)Jan 31, 2019 | |
---|---|---|
Operating Cash Flow (Indirect Method) | ||
Cash flow from continuing operating activities | 18.46%-23.75M | -29.13M |
Net income from continuing operations | 16.64%-81.04M | ---97.23M |
Depreciation and amortization | -1.61%73.01M | --74.21M |
Deferred tax | 59.96%-2.06M | ---5.14M |
Other non cash items | -209.40%-128K | --117K |
Change In working capital | -313.47%-15.26M | ---3.69M |
-Change in receivables | -82.77%7.08M | --41.07M |
-Change in inventory | 108.17%1M | ---12.25M |
-Change in prepaid assets | -508.02%-5.91M | ---972K |
-Change in payables and accrued expense | 128.10%6.45M | ---22.96M |
-Change in other current liabilities | --45.46M | --0 |
-Change in other working capital | -707.77%-69.34M | ---8.58M |
Cash from discontinued investing activities | ||
Operating cash flow | 18.46%-23.75M | ---29.13M |
Investing cash flow | ||
Cash flow from continuing investing activities | -119.09%-61.83M | -28.22M |
Capital expenditure reported | -199.47%-33.47M | ---11.18M |
Net PPE purchase and sale | 15.03%-13.36M | ---15.72M |
Net business purchase and sale | --0 | ---1.31M |
Net other investing changes | -124,900.00%-15M | ---12K |
Cash from discontinued investing activities | ||
Investing cash flow | -119.09%-61.83M | ---28.22M |
Financing cash flow | ||
Cash flow from continuing financing activities | 127.18%115.86M | 51M |
Net issuance payments of debt | -110.78%-5.5M | --51M |
Net other financing activities | --121.36M | ---- |
Cash from discontinued financing activities | ||
Financing cash flow | 127.18%115.86M | --51M |
Net cash flow | ||
Beginning cash position | -10.31%63.39M | --70.68M |
Current changes in cash | 576.65%30.28M | ---6.35M |
Effect of exchange rate changes | 79.25%-194K | ---935K |
End cash Position | 47.46%93.47M | --63.39M |
Free cash flow | -25.98%-70.58M | ---56.03M |
Currency Unit | USD | USD |
Audit Opinions | Unqualified Opinion with Explanatory Notes | -- |
No Data